CARRIE SEVERA: Open Payments
NPI 1568727741 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 19 payments from 7 companies in 2025. Trend: 2023 $22 · 2024 $190 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 10 | $117 |
| Astellas Pharma US Inc | 3 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Octapharma USA, Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| CooperSurgical, Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
Products named: Veozah, MYFEMBREE, FIBRYGA, Lynkuet, Paragard T 380A, SLYND.
Industry payments across IA — which companies pay providers there.
